EMN vs NVCR · P/E 21, rev $9.38B vs rev $357.6M
Eastman Chemical Company (EMN) versus Novocure Ltd (NVCR) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Novocure Ltd (NVCR) is a medical devices company listed on US.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. NVCR currently screens at market cap $1.99B.
Not investment advice. Open the EMN and NVCR stock pages for the full models.
Not investment advice.